Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:08 PM
Ignite Modification Date:
2025-12-24 @ 10:08 PM
NCT ID:
NCT00816335
Eligibility Criteria:
Inclusion Criteria:
* Patients must be 18 years of age or older.
* Patients must either have a histologic-confirmed solid malignancy or have a suspected solid malignancy which has required a diagnostic preoperative PET/CT scan or for which a diagnostic preoperative PET/CT scan has been recommended
* Patients must clinically have been determined to be a candidate for the indicated surgical procedure.
* Patients may have had prior surgery and/or chemotherapy with no limit to the number of prior therapeutic procedures or chemotherapeutic regimens.
* Patients must have a performance status of 0, 1 or 2 by ECOG standards.
* Patients must give written informed consent, including consent to have IV line placed for 18F-FDG administration.
* Females of childbearing age must have a negative pregnancy test (by Beta HCG qualitative analysis), must have had a history of a surgical sterilization, or must give history of no menses in past twelve months.
* Fasting blood sugar less than 200 mg/dl.
Exclusion Criteria:
* Any patient with active CNS tumor involvement.
* Any patient who is pregnant or lactating.
* Any patient with a body size and habitus that is determined to prohibit use of the diagnostic equipment.
* Any patient with a tumor burden that is determined to be so great (as determined by preoperative PET/CT scanning or intraoperative findings) that further surgery is not advised.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00816335
Study Brief:
Protocol Section:
NCT00816335